Product Name | Benfotiamine |
Specification | 99% min |
Appearance | White powder |
CAS | 22457-89-2 |
Molecular Formula | C19H23N4O6PS |
Test Method | HPLC, UV |
OEM Service | Customized as guests request—Benfotiamine capsules |
Shelf time | 2-5 years(keep away sunlight, keep dry) |
Test Method | HPLC |
Payment | T/T, Western union, Secure payment, L/C and T/T |
Test Item | Analysis Specification | Result |
Description | White to almost white crystal | White to almost white crystal |
Identification | A: IR spectra shows the similarity between sample and standard
B: The retention time of the major peak corresponds with it of the reference standard |
Complies
Complies |
Solution color and clearness | Colorless to pale-yellow clear solution | Complies |
Chlorides | Not more than 0.053% | <0.053% |
Sulphate | Not more than 0.011% | <0.011% |
Loss on drying | Not more than 1.5% | 0.66% |
Heavy metals | Not more than 0.002% | <0.002% |
Related Substances | TMP :Not more than 0.15%
Benzoic acid :not more than0.1% Amide: not more than 0.40% Single unknown impurity: not more than0.1% Thiamine: not more than0.1% Total impurities: Not more than 1.5%
|
<0.025%
No detectable 0.06% 0.08% No detectable 0.33%
|
Residual solvents | Dichloromethane:not more than 600ppm
Isopropanol: not more than 300ppm |
No detectable
64ppm
|
Microbial limits | Total bacteria: not more than100cfu/g
Yeast and mould: not more than50cfu/g Escherichia coli: no detectable |
<10 cfu/g
<10 cfu/g No detectable |
Assay(Dry Basis) | 98.0%~102.0% | 99.6% |
Conclusion | Complies with company Standard. |
A drug for the treatment of cardiovascular diseases
Packaging:25 kg/package , as customer’s request
Shipping:It can be according to the customer’s request
2-8°C
Benfotiamine is a fat-soluble derivative of vitamin B1, which improves the shortcomings of low bioavailability of water-soluble vitamin B1, increases the concentration of thiamine in the blood and tissues, and improves the curative effect.